| Alton | We'd like to offer you the job http://www.crickethillwinery.com/slevotra.html slevotra price It's not a huge new market--analysts see $200 million in additional sales--but it's a needy one. Nexavar would be pointed toward patients whose cancer has returned after surgery and radiation--patients whose treatment options are limited, and prognosis poor. Plus, adding indications one by one--small or not-so-small--is a common strategy for keeping sales growth coming, particularly in cancer. Nexavar, also known as sorafenib, is under study for several other groups of cancer patients. |
|